Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology · 2024
DOI: 10.1016/j.cgh.2023.12.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von Sanjay K Murthy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; The Ottawa Hospital Inflammatory…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Persons with inflammatory bowel disease (IBD) affecting the colorectum (cIBD) have a 1.5- to 2-fold higher risk of developing colorectal cancer (CRC) relative to age- and sex-matched members of the general population.1 Intensive surveillance colonoscopy is recommended in this population to detect and treat early neoplastic lesions before they evolve to incurable cancers.2 Some societies advocate for widespread non-targeted ("random") biopsies throughout the colorectum to screen for "invisible" neoplastic lesions, in addition to targeted biopsies and/or resection of visible lesions.2 Despite the theoretical value of non-targeted biopsies in this setting, there are no high-quality, controlled data to support this practice. In addition to adding significant time and costs to colonoscopy screening, extensive biopsy sampling may also increase the risk of colorectal bleeding and bowel perforation, particularly in elderly patients and those receiving anticoagulant/antiplatelet therapies. With the widespread adoption of disease-modifying biologic and small molecule therapies,3 mucosal healing as a treatment end point,4 high-definition endoscopes,5 and endoscopy quality standards,6 as well as reports of very low neoplasia yield for non-targeted biopsies (0.1%-0.2% of biopsies),7 many experts have started to question the value of non-targeted biopsies as an adjunct for neoplasia surveillance in persons with cIBD.8 However, a recent large French cohort study reported that non-targeted biopsies still identify up to 20% of all neoplastic foci in persons with cIBD,9 albeit primarily in individuals with other major CRC risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine and, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; The Ottawa Hospital Inflammatory Bowel Disease Centre, Ottawa, Ontario, Canada; Ottawa Hospital Resear…
- Division of Gastroenterology, Department of Internal Medicine, Max Rady Faculty of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; University of Manitoba IBD Clinical and Researc…
- Centre for Inflammatory Bowel Disease, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Gastroenterology and Hepatology, University of Toronto, Toronto, Ontario, Canada.
- Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada; London Health Sciences Centre, University Hospital, London, Ontario, Canada.
- Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
- Department of Medicine and, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Murthy, S. K., Bernstein, C. N., Nguyen, G. C., Jairath, V., Riddell, R., Fergusson, D., & Canadian IBD Research Consortium (2024). Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.12.007
Vancouver
Murthy SK, Bernstein CN, Nguyen GC, Jairath V, Riddell R, Fergusson D, et al. Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2023.12.007
BibTeX
@article{Murthy2024,
author = {Murthy, Sanjay K and Bernstein, Charles N and Nguyen, Geoffrey C and Jairath, Vipul and Riddell, Robert and Fergusson, Dean and Canadian IBD Research Consortium, Canadian IBD Research Consortium},
title = {Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
doi = {10.1016/j.cgh.2023.12.007}
}
EUVIMED